JPMorgan Maintains Neutral on Teladoc Health (NYSE:TDOC), Lowers Price Target to $33By legume / March 6, 2023 / JPMorgan, Teladoc Health JPMorgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $35 to $33.